70 Biggest Movers From Friday

Gainers

  • InnSuites Hospitality Trust IHT shares gained 43.4% to close at $3.50 on Friday.
  • Velocity Financial, Inc. VEL rose 36.6% to close at $12.50 following Q1 earnings.
  • Yield10 Bioscience, Inc. YTEN jumped 26.2% to close at $10.83.
  • The L.S. Starrett Company SCX gained 26.2% to close at $7.85 after reporting higher quarterly earnings.
  • Orgenesis Inc. ORGS gained 24.4% to settle at $5.66 after the company swung to a Q1 profit.
  • Regional Health Properties, Inc. RHE rose 24.2% to close at $18.60 after dropping 23% on Thursday.
  • Core Molding Technologies, Inc. CMT surged 23.5% to close at $13.98 after the company reported higher Q1 earnings.
  • MoneyGram International, Inc. MGI gained 22.8% to settle at $8.03after the company reported better-than-expected Q1 sales results. The company issued Q2 sales guidance above analyst estimates.
  • Cooper-Standard Holdings Inc. CPS jumped 21.9% to close at $34.88 following strong quarterly sales.
  • Phio Pharmaceuticals Corp. PHIO gained 21.9% to settle at $2.67.
  • Epizyme, Inc. EPZM surged 21.7% to close at $8.29 after SVB Leerink upgraded the stock from Market Perform to Outperform and raised its price target from $12 to $16per share.
  • MEDNAX, Inc. MD gained 20% to close at $32.10 after the company reported better-than-expected Q1 results.
  • Funko, Inc. FNKO surged 19.9% to settle at $25.45 after the company reported better-than-expected Q1 results.
  • Y-mAbs Therapeutics, Inc. YMAB gained 19.3% to close at $34.20 after reporting a Q1 profit.
  • Bill.com Holdings, Inc. BILL climbed 18.3% to close at $154.23 after the company reported better-than-expected Q3 results and issued strong Q4 guidance.
  • LM Funding America, Inc. LMFA shares jumped 17.8% to close at $4.47. The company announced a 1-for-5 reverse stock split effective May 7.
  • Pro-Dex, Inc. PDEX jumped 17.3% to close at $34.37 after reporting a rise in quarterly earnings.
  • Golden Entertainment, Inc. GDEN gained 17.2% to close at $41.91 after the company reported better-than-expected Q1 sales results.
  • iBio, Inc. IBIO rose 16.7% to close at $1.61 after the company provided an update on its IBIO-201 program and reported on its progress in developing a second-generation subunit vaccine candidate, IBIO-202, being designed for the prevention of SARS-CoV-2 infection.
  • Auris Medical Holding Ltd. EARS surged 16.6% to settle at $3.3450 after the company issued an update on Bentrio program in allergy.
  • EMCORE Corporation EMKR rose 16.5% to settle at $7.28. The company, last week, reported better-than-expected Q2 EPS and sales results.
  • Recro Pharma, Inc. REPH gained 16.3% to settle at $2.92 following strong Q1 results.
  • BioVie Inc BIVI gained 16.3% to close at $15.35.
  • Atossa Therapeutics, Inc. ATOS rose 16.1% to settle at $2.74.
  • Qurate Retail, Inc. QRTEA jumped 15.9% to close at $13.70 following upbeat quarterly results.
  • BlueLinx Holdings Inc. BXC gained 15.8% to settle at $66.81.
  • Clene Inc. CLNN surged 15.3% to close at $9.19.
  • PubMatic, Inc. PUBM rose 14.9% to settle at $44.62.
  • Tilray, Inc. TLRY climbed 14.4% to close at $16.18 after Jefferies upgraded the stock from Underperform to Buy and raised its price target from $4.77 to $23 per share.
  • Assertio Holdings, Inc. ASRT shares gained 14.3% to settle at $0.57 after the company reported better-than-expected Q1 results.
  • CarGurus, Inc. CARG gained 13.6% to settle at $27.35 after the company reported better-than-expected Q1 EPS and sales results.
  • Nikola Corporation NKLA gained 13.4% to close at $11.50 after the cpmpany posted a narrower-than-expected quarterly loss.
  • ADTRAN, Inc. ADTN climbed 13.3% to settle at $19.93. The company recently released Q1 results.
  • The Manitowoc Company, Inc. MTW surged 12.4% to close at $27.26.
  • Roku, Inc. ROKU shares gained 11.6% to settle at $317.00 after the company reported better-than-expected Q1 results and issued strong Q2 revenue guidance.
  • Cyclerion Therapeutics, Inc. CYCN shares gained 10.8% to close at $2.76.
  • Tabula Rasa HealthCare, Inc. TRHC gained 10.5% to close at $47.13 after reporting Q1 results.
  • Avalon Holdings Corporation AWX rose 8.8% to close at $4.51.
  • Datadog, Inc. DDOG rose 8.3% to close at $77.29 after the company reported better-than-expected Q1 results and issued sales guidance above estimates.
  • Diana Shipping Inc. DSX gained 7% to settle at $3.98 after the company reported a time chart contract for m/v Myrsini with Bocimar.
  • CureVac N.V. CVAC rose 6.9% to settle at $100.40 after dropping over 7% on Thursday.
  • Expedia Group, Inc. EXPE rose 5.2% to close at $173.46 after the company reported better-than-expected Q1 results.

 

Check out these big penny stock gainers and losers

Losers

  • ChemoCentryx, Inc. CCXI shares tumbled 62% to close at $10.46 on Friday after the company said the FDA's Arthritis Advisory Committee that evaluated avacopan for the treatment of antineutrophil cytoplasmic autoantibody-associated vasculitis gave a split verdict on whether the efficacy data support approval of avacopan. The committee voted 9-7 in favor of safety and 10-8 that the benefit-risk profile is adequate to support approval of avacopan at the proposed dose of 30 mg twice daily.
  • Orphazyme A/S ORPH dipped 32.2% to settle at $5.75 after the company announced that the ORARIALS-01 pivotal trial of arimoclomol in amyotrophic lateral sclerosis (ALS) did not meet its primary and secondary endpoints.
  • Centerra Gold Inc. CGAU fell 29.8% to close at $6.92.
  • SIFCO Industries, Inc. SIF dropped 22.5% to settle at $9.90 after reporting a loss for the second quarter.
  • SemiLEDs Corporation LEDS fell 22.2% to close at $7.95.
  • Aemetis, Inc. AMTX dropped 21.3% to settle at $13.07.
  • F-star Therapeutics, Inc. FSTX fell 19.6% to settle at $7.13 after the company priced its 9.29 million shares common stock offering at $7 per share.
  • SunLink Health Systems, Inc. SSY dropped 19.4% to close at $3.45.
  • Waterdrop Inc. WDH fell 19.2% to close at $9.70 after the company priced its IPO at $12 per ADS.
  • Natural Grocers by Vitamin Cottage, Inc. NGVC dipped 18.8% to close at $12.95 after the company reported a decline in quarterly earnings.
  • Aurinia Pharmaceuticals Inc. AUPH fell 17.8% to close at $10.15 after the company reported a wider Q1 loss.
  • Drive Shack Inc. DS dropped 17.7% to settle at $2.80 after reporting a Q1 loss.
  • American Shared Hospital Services AMS shares declined 17.6% to close at $3.41.
  • Teradata Corporation TDC fell 16.3% to settle at $40.54 after the company issued weak FY21 earnings forecast.
  • MoSys, Inc. MOSY dropped 15.9% to close at $3.28 after the company issued Q2 sales guidance below analyst estimates.
  • ShiftPixy, Inc. PIXY shares fell 15.6% to close at $2.54 after jumping 25% on Thursday.
  • Shake Shack Inc. SHAK fell 15.3% to close at $89.48 after the company reported downbeat Q1 sales and issued weak Q2 sales guidance.
  • Travere Therapeutics, Inc. TVTX dropped 14.8% to close at $20.01 following weak quarterly results.
  • Precipio, Inc. PRPO fell 14.7% to settle at $3.84.
  • JFrog Ltd. FROG fell 14.6% to close at $35.91 after the company reported Q1 earnings results.
  • Home Point Capital Inc. HMPT dropped 14.5% to close at $6.60. Piper Sandler downgraded Home Point Capital from Overweight to Neutral and lowered the price target from $18 to $8.
  • Charles & Colvard, Ltd. CTHR fell 13.7% to close at $2.83 after the company reported Q3 earnings results.
  • Universal Electronics Inc. UEIC tumbled 13.6% to settle at $50.58 following weak quarterly sales.
  • Waitr Holdings Inc. WTRH dropped 12.4% to settle at $2.13 after the company reported worse-than-expected Q1 earnings.
  • Farmer Bros. Co. FARM fell 10.8% to close at $9.28 after the company reported worse-than-expected Q3 results.
  • Installed Building Products, Inc. IBP fell 7.5% to close at $127.57 after the company reported worse-than-expected Q1 results.
  • Stealth BioTherapeutics Corp MITO fell 6.2% to close at $1.52. Stealth BioTherapeutics shares jumped 35% on Thursday in reaction to new data from a post hoc analysis of Phase 1 ReCLAIM study evaluating elamipretide in patients with noncentral geographic atrophy (GA) and high-risk drusen associated with dry age-related macular degeneration (AMD).
  • Global Partners LP GLP shares fell 5% to close at $24.84 after the company reported worse-than-expected Q1 earnings.
Posted In: Movers From YesterdayTop GainersNewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading Ideas